Tuberculous Meningitis With Paradoxical Reaction in an Immunocompetent Young Male Treated by Interleukin-1 Receptor Antagonist. [PDF]
Kanat A +4 more
europepmc +1 more source
DAIR to Be Different: Successful Use of DAIR Regimen, a Novel Treatment Combination for EBV-induced HLH. [PDF]
Bouhadana A, Steinberg A.
europepmc +1 more source
Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the Literature [PDF]
Catharina M. Mulders‐Manders +3 more
openalex +1 more source
4CPS-160 Efficacy and safety of anakinra and canakinumab for the treatment of IL-36R antagonist deficiency [PDF]
María Sáez-Torres de Vicente +5 more
openalex +1 more source
Hemophagocytic Lymphohistiocytosis: A Life-Threatening Hyperinflammatory Syndrome. [PDF]
Khan T +4 more
europepmc +1 more source
EP18 Use of anakinra for haemophagocytic lymphohistiocytosis in adults [PDF]
Luke Sammut +4 more
openalex +1 more source
Tinea labialis in a patient with Schnitzler syndrome on interleukin-1 receptor antagonist. [PDF]
Mooney N +4 more
europepmc +1 more source
SAT0626 Anakinra treatment in refractory cases of adult-onset still disease: case series [PDF]
Serdal Uğurlu +4 more
openalex +1 more source

